Aromatase excess syndrome
Overview
Aromatase excess syndrome is a rare genetic and endocrine disorder that causes the body to produce too much estrogen
A rare condition where genetic changes lead to the overexpression of the aromatase enzyme.
Symptoms
Symptoms in Males
Gynecomastia: Enlargement of breast tissue, usually starting in late childhood or adolescence and lasting for life.
Advanced Bone Age: Bones grow and mature much faster than normal during childhood.
Short Stature: Early growth spurts cause boys to be tall as children, but premature closing of the growth plates results in a shorter final height as an adult.
Feminizing Features: High estrogen can cause a higher-pitched voice, sparse facial hair, and mild hypogonadotropic hypogonadism (low testosterone levels).
Normal Fertility: Ability to have children is typically unaffected despite hormone shifts.
Symptoms in Females
Macromastia: Excessive or early breast growth.
Menstrual Irregularities: Early onset of menstruation (precocious puberty) or irregular periods.
Short Stature: Similar to males, accelerated bone maturation leads to reduced adult height.
Mild or Absent Signs: Many females with the genetic trait show very mild or no visible symptoms at all.
Causes
Autosomal dominant inheritance: The condition is typically passed down in families through a dominant genetic trait.
Genomic rearrangements: Cryptic rearrangements around the CYP19A1 gene cause the enzyme to become overexpressed or hyperactive (a gain-of-function effect).
Duplications: Extra copies of the gene increase the number of physiological promoters, raising production levels.
Deletions and inversions: These structural changes form chimeric genes that fuse parts of neighboring genes with CYP19A1 coding exons, driving widespread expression in various tissues.
High estrogen conversion: Extra enzyme activity converts high amounts of circulating androgens (male hormones) into estradiol and estrone (estrogens).
Hyperestrogenism: The resulting excess estrogen triggers early or prepubertal physical changes, rapid bone maturation, and short final adult height in both males and females.
Diagnosis
Clinical Criteria: Suspected when a male patient shows bilateral breast enlargement (gynecomastia) starting before or during early puberty (ages 5 to 14), paired with an autosomal dominant family history and advanced bone age leading to short adult stature.
Hormone Profile: Blood tests often show elevated levels of estrogens—particularly estrone, which is more commonly elevated than estradiol. Testosterone levels may be low for the patient's age, and gonadotropins (FSH and LH) are typically low or low-normal. Note that normal estradiol levels do not completely rule out the syndrome
Definitive Genetic Testing: Molecular analysis of the CYP19A1 gene using blood mononuclear cells is mandatory for a confirmed diagnosis, identifying specific gains of function, duplications, inversions, or deletions.
Pubertal Gynecomastia: Common, temporary breast enlargement in adolescent boys that typically resolves on its own within one to two years without accelerated bone growth..
Klinefelter Syndrome: Another genetic cause of gynecomastia and hypogonadism that is ruled out via standard karyotyping.
Treatment
Aromatase Inhibitors (AIs): Drugs like letrozole and anastrozole block the aromatase enzyme. This stops the excessive conversion of androgens into estrogens
Hormone Balance: Treatment lowers blood levels of estrone and estradiol while raising testosterone.
In Children: Early use helps prevent premature bone closure, increases final adult height, and stops early breast development (gynecomastia) in boys or premature thelarche in girls.
Alternative Medications: Doctors may also use gonadotropin-releasing hormone (GnRH) analogues, non-aromatizable androgens (like dihydrotestosterone) in males, or high-dose progestogens in females to help suppress estrogen activity.
Mastectomy: If gynecomastia is severe, persistent, or causes major emotional distress, surgical procedures like subcutaneous mastectomy or liposuction may be performed.Prevention:
Bone Health: Doctors regularly check bone density using DEXA scans because hormone shifts and treatments can affect bone strength.Individual Plans: Endocrinologists tailor doses based on age, symptom severity, and growth patterns.
Type of Doctor Department :A pediatric endocrinologist
.jpg)
Comments
Post a Comment